Michael systems as transglutaminase inhibitors
US8471063B2 · kind B2 · utility
4Cited by
0References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 8, 2007 |
| Grant date | Jun 25, 2013 |
| Priority date | — |
| Expiry date | Nov 26, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K7/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are peptide derivatives and peptidomimetics as inhibitors for transglutaminases, methods for their preparation, pharmaceutical compositions containing said compounds as well as uses of said transglutaminase inhibitors in particular for the treatment of coeliac disease and transglutaminase dependent diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.